Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Therapeutics Inc (OTCQB:BTHE)

0.0692
Delayed Data
As of Feb 16
 0.00 / 0.00%
Today’s Change
0.03
Today|||52-Week Range
0.17
-1.14%
Year-to-Date
No recent news for Boston Therapeutics Inc.

Today’s Trading

Previous close0.07
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)16,370
Market cap$3.1M
Dividend yield--
Data as of 02/16/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)+266.67%
Earnings growth (next 5 years)--
Revenue growth (last year)-50.43%
P/E ratioNM
Price/Sales43.25
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting dateMarch 31, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$98.9K
Annual profit (last year)-$2.5M
Net profit margin-2,516.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer
Carl W. Rausch
Chief Financial Officer
Stephen A. Spanos
Corporate headquarters
Newton, Massachusetts

Forecasts


Search for Jobs